• 0
MENU
Cart Details

Cabaza Tablet ER

Product Informations: Cabaza Tablet ER

In Peripheral vascular disease Peripheral vascular disease refers to the condition of disturbed blood circulation in blood vessels. Cabaza Tablet ER prevents blood from clotting inside the veins and arteries. This helps the blood flow freely around your body thereby preventing a heart attack or stroke (or deep vein thrombosis or pulmonary embolism). It helps prevent the formation of blood clots and also prevents the existing ones from growing bigger in size. Make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine. In Intermittent claudication Intermittent claudication refers to muscle pain on mild exertion (ache, cramp, numbness or sense of fatigue), classically in the calf muscle, which occurs during exercise or even walking, and it gets better with a short period of rest. Cabaza Tablet ER helps relieve this pain in the legs that is caused due to disturbed blood supply in the legs. It helps prevent formation of blood clots, improves blood flow and maintains free flowing of blood in your body.

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Cabaza Tablet ER is to be taken with food.
Cabaza Tablet ER is used to treat peripheral vascular disease (poor circulation to the arms and legs) and intermittent claudication (pain on walking or at rest caused by poor circulation to the legs). It works by increasing the blood flow to the arms and legs. Cabaza Tablet ER reduces cramping in the legs that occur on walking in such patients. It also has beneficial effects in alcohol-related liver damage. This medicine should be taken regularly as advised by the doctor. You should take it with food and at a fixed time. You should never stop it abruptly without consulting the doctor. This medicine is only one part of a treatment program which should also include a healthy diet, regular exercise, and smoking cessation. It may cause side effects like nausea, vomiting, diarrhea, headache, flushing (sense of warmth in the face, ears, neck, and trunk), and weakness. This medicine may not be suitable for some people. You must inform the doctor if you are suffering from any liver or kidney disease. Also, let your doctor know about all the other medications that you are using regularly. This medicine is not usually recommended during pregnancy or breastfeeding, so always consult your doctor before taking it.
  • Diarrhea
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Headache
  • Heartburn
  • Lightheadedness
  • Nausea
  • Stomach discomfort
  • Vomiting
  • Weakness
Alcohol : CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Cabaza Tablet ER. Please consult your doctor.

Pregnancy : CONSULT YOUR DOCTOR

Cabaza Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding : SAFE IF PRESCRIBED

Cabaza Tablet ER is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.

Driving : UNSAFE

Cabaza Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney : CAUTION

Cabaza Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Cabaza Tablet ER may be needed. Please consult your doctor.

Liver : CONSULT YOUR DOCTOR

There is limited information available on the use of Cabaza Tablet ER in patients with liver disease. Please consult your doctor.

If you miss a dose of Cabaza Tablet ER, skip it and continue with your normal schedule. Do not double the dose.

Chemical Class::Methylxanthine Derivative|Habit Forming::No|Therapeutic Class::CARDIAC|Action Class::Rheologic modifier

FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra


Alternatives and Substitutes


Customer Reviews

No customer reviews yet.

References

FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More

European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More

ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More

Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More



Available options.

Same salt composition: Pentoxifylline (400mg)

Test Buy medical disposable face mask
to protect your loved ones